Home > Polymers, Specialty Chemicals & Advanced Materials > Fluorapatite Market
Fluorapatite Market size is anticipated to gain momentum from 2023 to 2032, given the extensive product usage in the synthesis of phosphoric acid and hydrogen fluoride. In the pharmaceutical industry, hydrogen fluoride is utilized as a source of hydrofluoric acid, a starting agent in pharma fluorine component production.
An increase in government investment in drug manufacturing projects will therefore boost the adoption of fluorapatite mineral. Citing an instance, in March 2023, the biomanufacturing and life sciences industry obtained a USD 80.5 million boost in federal funding. This initiative was intended to commercialize discoveries and supply life-saving drugs including antivirals in Canada, augmenting product consumption.
Fluorapatite refers to a hard crystalline phosphate mineral that occurs as an accessory mineral in metamorphic and igneous rocks. The mineral is also extensively found in phosphorite ore deposits and sedimentary rocks. Moreover, it can be synthesized through the combination of phosphate and calcium salts to generate calcium phosphate to further react with fluoride sources to obtain this mineral.
The emphasis on agricultural development and the subsequent rise in demand for fertilizers are among the prominent factors fostering the fluorapatite market trends. For example, under the European Union’s multiannual financial framework for 2021-2027, nearly USD 422.3 billion was allocated for CAP (common agricultural policy) funds. Furthermore, population growth and the high concern for food security will bolster fluorapatite formation for use as a source of phosphate fertilizers.
However, LED bulbs have emerged as a suitable alternative to fluorescent tubes, owing to low power consumption and long lifespan. In addition, the increased competition in the electronics sector may create a hindrance to the market dynamics over the forecast period.
Pharmaceutical grade is expected to be a lucrative segment for the fluorapatite market by 2032, on account of the rising cancer prevalence. Fluoro-pharmaceuticals have also been utilized for a range of therapeutic purposes, such as anti-inflammatory and antimicrobial. The strong focus on mitigating the spread of infectious diseases will therefore accelerate fluorapatite production for pharmaceutical applications.
The dentistry application segment will account for a major the fluorapatite market share over the forthcoming years, considering the ability of fluoride to inhibit the development of cavities and tooth decay. According to data from the CDC, over 90% of adults aged 20 years and above have had at least one cavity. The potential increase in elderly people will further escalate the adoption of fluorapatite enamel since they are susceptible to either root or coronal caries.
North American fluorapatite market size will garner commendable profits by 2032, owing to the escalating pharma expenditure. As per the Assistant Secretary for Planning and Evaluation, in 2021, U.S. healthcare systems invested USD 603 billion on prescription drugs, of which $421 billion was on retail drugs, mainly due to the rise in spending per prescription. Additionally, the mounting mineral production and its application scope in chemical manufacturing facilities will add impetus to the regional market development over the foreseeable future.
Fluorapatite market Key manufacturers include ICL, Crystal Classics Ltd., GB Minerals Ltd., and Dakota Matrix, among others. These companies are incorporating strategies such as product developments, collaborations, and acquisitions to increase their product portfolio, expand their consumer base, and reinforce their presence in the industry.
The intensifying Russia-Ukraine conflict has caused major economic turmoil worldwide. Countries that are directly and indirectly dependent on these two countries for various commodities, including pharmaceuticals and fertilizers, have been severely impacted. Since Ukraine was also considered a thriving synthetic chemical producer, the economic impacts and other setbacks due to the war may limit fluorapatite production over the estimated timeline.